neurology

News

Reviews underway of first drug for rare disease MOGAD

Patients with rare autoimmune disease MOGAD could be months away from having a first approved therapy, as the FDA starts a review of Roche's Enspryng.

News

Person holds hand of elderly lady; grey colour scheme

Major trial of Roche Alzheimer's drug kicks off in Europe

The PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.

News

Novartis sets sights on new oral MS drug after phase 3 wins

Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.

News

Centre for Ageing image of seated exercise class

Alzheimer's patients 'not changing brain health behaviours'

Researchers have found that people with early Alzheimer's are not following guidelines for promoting brain health, even if they are on drug therapy.

News

Biogen, Ionis trumpet Alzheimer's data, but shares dip

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.

News

Bayer's asundexian starts EU review for ischaemic stroke

The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.

Reviews underway of first drug for rare disease MOGAD

Major trial of Roche Alzheimer's drug kicks off in Europe

Novartis sets sights on new oral MS drug after phase 3 wins

Alzheimer's patients 'not changing brain health behaviours'

Biogen, Ionis trumpet Alzheimer's data, but shares dip

Bayer's asundexian starts EU review for ischaemic stroke

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

neurology

Editor's Picks